FDA Warning Letter — Namsa

Case 544884 — FEI 3010138955

The FDA took a Warning Letter action against Namsa on Mar 23, 2018 (Minneapolis, MN). The action was issued by CDRH and concerns devices products.

Action Details

Facility
Namsa
Date
Mar 23, 2018
Fiscal Year
2018
Product Type
Devices
Center
CDRH
Location
Minneapolis, MN (United States)